Data-driven

AI-Driven Study Redefines Right Heart Health Assessment With Novel Predictive Model

Retrieved on: 
Thursday, January 4, 2024
Cardiology, UK Biobank, Data-driven, MRI, Survival, American Heart, ECG, American Heart Association, Mount Sinai Health System, Research, DL, Health, Yale School of Medicine, Doctor of Philosophy, Cardiomyopathy, National Institutes of Health, AI, Artificial intelligence, Ventricular septal defect, Lung, MBBS, Bangladesh Technical Education Board, Yale New Haven Hospital, Assistant, MPH, Patient, CTSA, Diagnosis, Intelligence, Journal, Public health, Pulmonary hypertension, Yale school, Medical device

NEW YORK, Jan. 4, 2024 /PRNewswire-PRWeb/ -- Departure from traditional methods marks a significant advance in evaluating heart health, paving the way for more innovative tools and improved patient outcomes

Key Points: 
  • "This novel method could expedite the identification of heart problems, especially in the right ventricle, and potentially lead to earlier and more effective treatment.
  • It holds particular importance for patients with congenital heart disease, who often face issues in the right ventricle."
  • "Our findings mark a significant leap forward in right heart health assessment, offering a glimpse into a future where AI plays a pivotal role in early and accurate diagnosis.
  • This study was supported by the National Heart, Lung, and Blood Institute, National Institutes of Health (R01HL155915), and National Center for Advancing Translational Sciences, National Institutes of Health (CTSA grant UL1TR004419).

What Is the Impact of Predictive AI in the Health Care Setting? Findings underscore the need to track individuals affected by machine learning predictions.

Retrieved on: 
Monday, October 9, 2023
Nursing care plan, Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, Internal medicine, Doctor of Philosophy, Beth Israel Deaconess Medical Center, Machine learning, Death, D3M, Sepsis, Urology, MPH, Roger Hawkins (drummer), Mortality, University, Annals of Internal Medicine, Artificial intelligence, Department of Medicine – University of Pamplona, Kidney, Use, Data-driven, Associate, Learning, Patient, Management, Nursing, MD, RN, Medicine

NEW YORK, Oct. 9, 2023 /PRNewswire-PRWeb/ -- Models built on machine learning in health care can be victims of their own success, according to researchers at the Icahn School of Medicine and the University of Michigan.

Key Points: 
  • Their study assessed the impact of implementing predictive models on the subsequent performance of those and other models.
  • Their study assessed the impact of implementing predictive models on the subsequent performance of those and other models.
  • "These findings are equally applicable outside of health care settings and extend to predictive models in general.
  • The paper is titled "Implications of the Use of Artificial Intelligence Predictive Models in Health Care Settings: A Simulation Study."

Survale Releases New "Data Driven Candidate Experience Maturity Model" White Paper

Retrieved on: 
Tuesday, September 19, 2023
Organization, IBM, Acquisition, Environment, Surval Montreux, SAN, Map, Data-driven, Sales, Management

SAN FRANCISCO, Sept. 19, 2023 /PRNewswire-PRWeb/ -- Talent feedback platform provider Survale announced today the release of a new white paper that provides a capability map that will show organizations clear steps to take in order to provide repeatable, data driven positive experiences for candidates as they go through the hiring process.

Key Points: 
  • "The Data Driven Candidate Experience Maturity Model" draws from the experiences of a large base of organizations to create a roadmap for understanding the capabilities required in order to effectively use feedback data to better manage the recruitment process.
  • Providing positive candidate experience has long been seen as a key to better hiring outcomes.
  • A Brandon Hall Group study found that organizations that prioritize candidate experience have a better quality of hire, with a 70% increase in the likelihood of hiring a top-quality candidate.
  • Each level of the maturity model provides increasing capabilities and ties them to the increased hiring benefits that each level can yield.

Mount Sinai Researchers Use New Deep Learning Approach to Enable Analysis of Electrocardiograms as Language

Retrieved on: 
Tuesday, June 6, 2023
National Center for Voice and Speech, Data-driven, Learning, Heart, Icahn School of Medicine at Mount Sinai, Department of Medicine – University of Pamplona, ChatGPT, National Heart, Lung, and Blood Institute, Pathology, ECG, Intelligence, CNN Pipeline, Lung, Language, CNN, Science, Hospital, Genetic disorder, Patient, Physician, Machine learning, Hypertrophic cardiomyopathy, Division, Algorithm, DOI, Architecture, Diagnosis, Artificial intelligence, Automated ECG interpretation, Mount Sinai Health System, MPH, NIH, Sinai, D3M, Disease, Medical device, Medical imaging, MD, Medicine

NEW YORK, June 6, 2023 /PRNewswire-PRWeb/ -- Mount Sinai researchers have developed an innovative artificial intelligence (AI) model for electrocardiogram (ECG) analysis that allows for the interpretation of ECGs as language. This approach can enhance the accuracy and effectiveness of ECG-related diagnoses, especially for cardiac conditions where limited data is available on which to train.

Key Points: 
  • Mount Sinai researchers have developed an innovative artificial intelligence (AI) model for electrocardiogram (ECG) analysis that allows for the interpretation of ECGs as language.
  • NEW YORK, June 6, 2023 /PRNewswire-PRWeb/ -- Mount Sinai researchers have developed an innovative artificial intelligence (AI) model for electrocardiogram (ECG) analysis that allows for the interpretation of ECGs as language.
  • Researchers are using a related image-generating model to create discrete representations of small parts of the ECG, enabling analysis of the ECG as language.
  • Researchers pretrained HeartBEiT on 8.5 million ECGs from 2.1 million patients collected over four decades from four hospitals within the Mount Sinai Health System.

weSure Digital Launches Innovative Commercial Insurance Product in its First US State

Retrieved on: 
Wednesday, February 15, 2023
Insurance, GWP, MetLife, WESR, Berkshire Hathaway, NTT, Berkshire Hathaway GUARD Insurance Companies, Data-driven, AM Best, Small, SME, Harel Group, Business owner's policy, Knowledge, Small business, Liability, Chief commercial officer, Traveler, TASE, Digital, BOP, MGA, NTT DATA, Cryptocurrency, Mobile phone, Management

New York, NY, Feb. 15, 2023 (GLOBE NEWSWIRE) -- WeSure Digital Insurance Services, Inc. (“weSure Digital”), the US Managing General Agency (MGA) subsidiary of the international publicly traded insurance and technology group WeSure Global Tech Ltd (TASE: WESR) which currently writes over $1 billion of Gross Written Premium (GWP) globally as a multi-line and multi-segment insurance carrier, announced today the launch of its fully digital insurance offering in the US, starting with Business Owners Policy (BOP) packaged Property & Liability insurance product in the State of Ohio.

Key Points: 
  • New York, NY, Feb. 15, 2023 (GLOBE NEWSWIRE) -- WeSure Digital Insurance Services, Inc. (“weSure Digital”), the US Managing General Agency (MGA) subsidiary of the international publicly traded insurance and technology group WeSure Global Tech Ltd (TASE: WESR) which currently writes over $1 billion of Gross Written Premium (GWP) globally as a multi-line and multi-segment insurance carrier, announced today the launch of its fully digital insurance offering in the US, starting with Business Owners Policy (BOP) packaged Property & Liability insurance product in the State of Ohio.
  • During the course of 2023, weSure Digital will expand to additional US States and will introduce additional products.
  • Emil Vainshel, Founder of weSure Global Tech and Chairman of the Board of weSure Digital, said: “We are thrilled to be launching this product and to offer our unique international digital insurance services now to the US market.
  • Barbara joins from Utica National Insurance Group, where she spent over 10 years in various product and distribution leadership roles, most recently leading Utica’s Small Commercial Segment.

Applied UV Declares Monthly Preferred Stock Dividend

Retrieved on: 
Tuesday, November 22, 2022
Health, Medical Devices, Infectious Diseases, Technology, Hospitals, Health Technology, Other Technology, FDA, Hospital, NASA, Health, Volatile organic compound, Infection, Allergen, Virus, Light-emitting diode, Chief Dental Officer (Canada), Research, Augustus A. Bird, Acquisition, Ozone, PCO, Data-driven, UVC, University, School, Pharmaceutical industry, UV

Applied UV, Inc. (NasdaqCM: AUVI ) (Applied UV or the Company), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (UVC) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced its Board of Directors has authorized the cash dividend to holders of Applied UVs 10.5% Series A Cumulative Perpetual Preferred Stock.

Key Points: 
  • Applied UV, Inc. (NasdaqCM: AUVI ) (Applied UV or the Company), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (UVC) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced its Board of Directors has authorized the cash dividend to holders of Applied UVs 10.5% Series A Cumulative Perpetual Preferred Stock.
  • Holders of the 10.5% Series A Cumulative Perpetual Preferred Stock (Nasdaq: AUVIP) shall receive a cash dividend equal to $0.21875 per share.
  • Applied UV is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets.
  • For more information about Applied UV, Inc., and its subsidiaries, please visit the following websites: https://www.applieduvinc.com/ ; https://sterilumen.com/ ; https://www.airocide.com https://kesscience.com ; https://scientificairmanagement.com and, https://munnworks.com/ .

Applied UV to Host Third Quarter 2022 Conference Call on November 15, 2022

Retrieved on: 
Friday, November 4, 2022
Communications, Medical Devices, Health, Health Technology, General Health, Public Relations, Investor Relations, Data-driven, Company, Augustus A. Bird, Virus, Research, LLC, Light-emitting diode, Hospital, Allergen, NASA, FDA, Volatile organic compound, Infection, Center for Food Safety and Applied Nutrition, UVC, University, Health, PCO, School, Investor relations, Acquisition, Ozone, Chief Dental Officer (Canada), Technology, Eyeish, Pharmaceutical industry, UV

Applied UV's management team will host an investor conference call and live webcast on November 15, 2022, at 9:00 am ET.

Key Points: 
  • Applied UV's management team will host an investor conference call and live webcast on November 15, 2022, at 9:00 am ET.
  • Investors can access the live webcast via a link on Applied UV's web site or at https://www.webcaster4.com/Webcast/Page/2626/47024 .
  • For those planning to participate on the call, please dial +1-877-545-0523 (for domestic calls), or +1-973-528-0016 (for international calls), passcode 583604.
  • Applied UV is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets.

Applied UV Announces New Debt Financings of $7.5 Million in Aggregate to Support Growth

Retrieved on: 
Tuesday, November 1, 2022
Medical Devices, Health, Technology, Infectious Diseases, Other Technology, Health Technology, Volatile organic compound, Eyeish, Augustus A. Bird, School, Acquisition, Partnership, Research, Virus, LLC, Industry, Hospital, PCO, R, Health, Pinnacle Bank Arena, Technology, University, Documentation, Ozone, Chief Dental Officer (Canada), Company, Light-emitting diode, FDA, Allergen, NASA, Infection, Note, UVC, Solution, Data-driven, Pharmaceutical industry, UV

This additional capital is expected to be used to support the Companys growth initiatives.

Key Points: 
  • This additional capital is expected to be used to support the Companys growth initiatives.
  • On October 7, 2022, Applied UV entered a securities purchase agreement whereby a single investor purchased an 18 month $2,807,500 Redeemable Note from the Company for $2,500,000.
  • Applied UV is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets.
  • For more information about Applied UV, Inc., and its subsidiaries, please visit the following websites: https://www.applieduvinc.com
    The information contained herein may contain forwardlooking statements.

TD SYNNEX Launches Data-IoTSolv with Focus on New Data and IoT Solutions

Retrieved on: 
Tuesday, October 25, 2022
Software, Mobile, Wireless, Networks, Professional Services, Internet, Data Management, Consumer Electronics, IOT (Internet of Things), Apps, Applications, Technology, Security, Data Analytics, Other Technology, Cloud, News, LinkedIn, Personal Data Privacy and Security Act of 2009, IBM, Growth, SYNNEX, Synnex, Organization, NYSE, Securities Exchange Act of 1934, Foundation, Twitter, Instagram, Securities Act of 1933, Facebook, Data-driven, TD, Artificial intelligence, Technology, Company, AI, CPG, Internet, Name, Solution, Engineering, IOT

Partnering with TD SYNNEX gave us access to technology, engineering, and product support to build an integrated IBM Cloud Pak for Data use-case for a major CPG client.

Key Points: 
  • Partnering with TD SYNNEX gave us access to technology, engineering, and product support to build an integrated IBM Cloud Pak for Data use-case for a major CPG client.
  • TD SYNNEX (NYSE: SNX) is a leading global distributor and solutions aggregator for the IT ecosystem.
  • Headquartered in Clearwater, Florida, and Fremont, California, TD SYNNEX 22,000 co-workers are dedicated to uniting compelling IT products, services and solutions from 1,500+ best-in-class technology vendors.
  • TD SYNNEX, the TD SYNNEX Logo, and all other TD SYNNEX company, product and services names and slogans are trademarks of TD SYNNEX Corporation.

Applied UV Declares Monthly Preferred Stock Dividend

Retrieved on: 
Monday, October 24, 2022
Biotechnology, Medical Devices, Infectious Diseases, Health, Health Technology, Health, Augustus A. Bird, Virus, NASA, LLC, Hospital, Research, Chief Dental Officer (Canada), Volatile organic compound, Allergen, Nasdaq, Technology, University, Company, Acquisition, PCO, Board, Data-driven, Ozone, Light-emitting diode, Infection, Board of directors, UVC, FDA, School, Pharmaceutical industry, UV

Applied UV, Inc. (NasdaqCM: AUVI ) (Applied UV or the Company), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (UVC) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced its Board of Directors has authorized the cash dividend to holders of Applied UVs 10.5% Series A Cumulative Perpetual Preferred Stock.

Key Points: 
  • Applied UV, Inc. (NasdaqCM: AUVI ) (Applied UV or the Company), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (UVC) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced its Board of Directors has authorized the cash dividend to holders of Applied UVs 10.5% Series A Cumulative Perpetual Preferred Stock.
  • Holders of the 10.5% Series A Cumulative Perpetual Preferred Stock (Nasdaq: AUVIP) shall receive a cash dividend equal to $0.21875 per share.
  • Applied UV is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets.
  • For more information about Applied UV, Inc., and its subsidiaries, please visit the following websites: https://www.applieduvinc.com/ ; https://sterilumen.com/ ; https://www.airocide.com ; https://kesscience.com ; https://scientificairmanagement.com and, https://munnworks.com/ .